N-ethyl-2-(5-methoxy-1H-benzimidazol-2-yl)ethanamine hydrochloride, 95.0%, 5g

Sulfamic acid, min. 99.3%, pa, ACS, 2.5 kg, plastic packaging.

(2E)-3-(2-fluorophenyl)-1-(4-methylphenyl)prop-2-en-1-one, 95.0%, 10g

Propyl 4-Hydroxybenzoate [for Biochemical Research]>99.0%(T)5g

tert-Butyl (1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropyl)carbamate, 95.0%, 100mg

tert-Butyl 3-(bromomethyl)benzoate, 95.0%, 500mg

(S)-3-benzyl-1-(tert-Butoxycarbonyl)piperidine-3-carboxylic acid, 97%, 100mg

1,2,3,5-Tetrahydro-4,1-benzoxazepine, 98%, 100mg

2-Bromo-4-chloro-5-fluoro-benzoic acid methyl ester, 97%, 100mg

p-Xylene, min. 99%, for synthesis, 500 ml, glass packaging

Flat flange reaction vial, cylindrical, graduated, with tempering jacket GL connecting piece, DN 60, 500 ml, 90 mm, 1 Piece

Barnidipine hydrochloride, 98.77%, 100mg

3-Methyloxolan-3-amine hydrochloride, 98%, 10g